An announcement from Faron Pharmaceuticals Oy ( (GB:FARN) ) is now available.
Faron Pharmaceuticals Oy has announced its Annual General Meeting (AGM) scheduled for March 21, 2025, in Turku, Finland. Key agenda items include the presentation of financial statements for 2024, where the company reported a loss of EUR 26 million, leading to a decision not to pay dividends. The AGM will also address board member elections, remuneration, and amendments to the company’s option program and Articles of Association, which aim to enhance the incentivization system and align with updated securities regulations.
More about Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a biopharmaceutical company focused on developing novel treatments for medical conditions with unmet needs. The company operates primarily in the pharmaceutical industry, with a market focus on innovative drug development.
YTD Price Performance: -15.85%
Average Trading Volume: 20,605
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £186.8M
See more data about FARN stock on TipRanks’ Stock Analysis page.